Research into hormonal male contraception focuses on suppressing spermatogenesis through combined androgen–progestin regimens. These therapies inhibit gonadotropin secretion, thereby reducing sperm production.
Clinical trials demonstrate promising efficacy; however, concerns regarding mood changes, metabolic effects, and long-term safety remain under evaluation.
Development of reversible, safe male contraceptive methods would represent a significant advancement in shared reproductive responsibility.
Continued research efforts are essential for clinical erotic implementation.
Leave a Reply